Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1912-1917
Published online before print September 26, 2002, doi: 10.1161/01.ATV.0000038485.94020.7F
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
22/11/1912    most recent
01.ATV.0000038485.94020.7Fv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kee, P.
Right arrow Articles by Barter, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kee, P.
Right arrow Articles by Barter, P. J.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Lipids
Right arrow Animal models of human disease
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1912.)
© 2002 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Metabolism of ApoA-I as Lipid-Free Protein or as Component of Discoidal and Spherical Reconstituted HDLs

Studies in Wild-Type and Hepatic Lipase Transgenic Rabbits

Patrick Kee; Kerry-Anne Rye; John L. Taylor; P. Hugh R. Barrett; Philip J. Barter

From the University Department of Medicine (P.K., P.J.B.), Royal Adelaide Hospital, and the Lipid Research Laboratory (P.K., K.-A.R., P.J.B.), Hanson Institute, Adelaide, Australia; the Gladstone Institute of Cardiovascular Disease (J.L.T.), University of California, San Francisco; and the Department of Medicine (P.H.R.B.), University of Western Australia and the Western Australian Institute for Medical Research, Perth, Australia.

Correspondence to Prof Philip J. Barter, Cardiovascular Investigation Unit, Level 6, Royal Adelaide Hospital, North Terrace, Adelaide, SA 5000, Australia. E-mail philip.barter{at}adelaide.edu.au

Objective— Apolipoprotein (apo)A-I exists in 3 forms in plasma: as lipid-free apoA-I, as a component of pre–ß-migrating discoidal high density lipoproteins (HDLs), and as a component of {alpha}-migrating spherical HDLs. This study investigates (1) the in vivo metabolism of apoA-I in each of these forms and (2) the effects of hepatic lipase (HL) on apoA-I metabolism.

Methods and Results— Wild-type and HL transgenic rabbits were studied. When lipid-free 125I-apoA-I and 125I-apoA-I in pre–ß-migrating discoidal reconstituted HDLs (rHDLs) were injected into wild-type rabbits, the label rapidly appeared in {alpha}-migrating particles and decayed with the same fractional catabolic rate (FCR) as when they were injected as a component of spherical rHDLs. Spherical rHDLs did not change in size when they were injected into wild-type rabbits but were reduced in size in HL transgenic rabbits. The FCR of apoA-I in HL transgenic rabbits was double that in wild-type rabbits.

Conclusions— In vivo, (1) lipid-free apoA-I rapidly incorporates into preexisting {alpha}-migrating particles, (2) pre–ß-migrating discoidal HDLs are rapidly converted into {alpha}-migrating HDLs, (3) the FCR of apoA-I is independent of the form in which it is introduced into plasma, and (4) HL reduces the size of {alpha}-migrating HDLs and increases the rate of catabolism of apoA-I.


Key Words: apolipoprotein A-I • hepatic lipase • high density lipoproteins • metabolism • rabbits




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
G. D. Wool, T. Vaisar, C. A. Reardon, and G. S. Getz
An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide
J. Lipid Res., September 1, 2009; 50(9): 1889 - 1900.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Mulya, J.-Y. Lee, A. K. Gebre, E. Y. Boudyguina, S.-K. Chung, T. L. Smith, P. L. Colvin, X.-C. Jiang, and J. S. Parks
Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL
J. Lipid Res., November 1, 2008; 49(11): 2390 - 2401.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Kee, D. Caiazza, K.-A. Rye, P.H.R. Barrett, L.A. Morehouse, and P.J. Barter
Effect of Inhibiting Cholesteryl Ester Transfer Protein on the Kinetics of High-Density Lipoprotein Cholesteryl Ester Transport in Plasma: In Vivo Studies in Rabbits
Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 884 - 890.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. J. Nicholls, B. Cutri, S. G. Worthley, P. Kee, K.-A. Rye, S. Bao, and P. J. Barter
Impact of Short-Term Administration of High-Density Lipoproteins and Atorvastatin on Atherosclerosis in Rabbits
Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2416 - 2421.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. J. Nicholls, G. J. Dusting, B. Cutri, S. Bao, G. R. Drummond, K.-A. Rye, and P. J. Barter
Reconstituted High-Density Lipoproteins Inhibit the Acute Pro-Oxidant and Proinflammatory Vascular Changes Induced by a Periarterial Collar in Normocholesterolemic Rabbits
Circulation, March 29, 2005; 111(12): 1543 - 1550.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P. G. Yancey, B. F. Asztalos, N. Stettler, D. Piccoli, D. L. Williams, M. A. Connelly, and G. H. Rothblat
SR-BI- and ABCA1-mediated cholesterol efflux to serum from patients with Alagille syndrome
J. Lipid Res., September 1, 2004; 45(9): 1724 - 1732.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J.-Y. Lee, L. Lanningham-Foster, E. Y. Boudyguina, T. L. Smith, E. R. Young, P. L. Colvin, M. J. Thomas, and J. S. Parks
Pre{beta} high density lipoprotein has two metabolic fates in human apolipoprotein A-I transgenic mice
J. Lipid Res., April 1, 2004; 45(4): 716 - 728.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K.-A. Rye and P. J. Barter
Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I
Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 421 - 428.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Denis, B. Haidar, M. Marcil, M. Bouvier, L. Krimbou, and J. Genest Jr.
Molecular and Cellular Physiology of Apolipoprotein A-I Lipidation by the ATP-binding Cassette Transporter A1 (ABCA1)
J. Biol. Chem., February 27, 2004; 279(9): 7384 - 7394.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Soro, M. Jauhiainen, C. Ehnholm, and M.-R. Taskinen
Determinants of low HDL levels in familial combined hyperlipidemia
J. Lipid Res., August 1, 2003; 44(8): 1536 - 1544.
[Abstract] [Full Text] [PDF]